FR12C0077I2 - Composition for the treatment of genital warts - Google Patents

Composition for the treatment of genital warts

Info

Publication number
FR12C0077I2
FR12C0077I2 FR12C0077C FR12C0077C FR12C0077I2 FR 12C0077 I2 FR12C0077 I2 FR 12C0077I2 FR 12C0077 C FR12C0077 C FR 12C0077C FR 12C0077 C FR12C0077 C FR 12C0077C FR 12C0077 I2 FR12C0077 I2 FR 12C0077I2
Authority
FR
France
Prior art keywords
treatment
composition
genital warts
warts
genital
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR12C0077C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Inst Chinese Academy Medical Sciences
Mitsui Norin Co Ltd
Original Assignee
Cancer Inst Chinese Academy Medical Sciences
Mitsui Norin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Inst Chinese Academy Medical Sciences, Mitsui Norin Co Ltd filed Critical Cancer Inst Chinese Academy Medical Sciences
Publication of FR12C0077I1 publication Critical patent/FR12C0077I1/fr
Application granted granted Critical
Publication of FR12C0077I2 publication Critical patent/FR12C0077I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
FR12C0077C 1996-11-18 2012-12-20 Composition for the treatment of genital warts Active FR12C0077I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32119596A JP3213557B2 (en) 1996-11-18 1996-11-18 A remedy for condyloma acuminatum containing tea catechin as an active ingredient

Publications (2)

Publication Number Publication Date
FR12C0077I1 FR12C0077I1 (en) 2013-02-01
FR12C0077I2 true FR12C0077I2 (en) 2013-08-16

Family

ID=18129859

Family Applications (1)

Application Number Title Priority Date Filing Date
FR12C0077C Active FR12C0077I2 (en) 1996-11-18 2012-12-20 Composition for the treatment of genital warts

Country Status (13)

Country Link
US (1) US5795911A (en)
EP (1) EP0842660B1 (en)
JP (1) JP3213557B2 (en)
KR (1) KR100312252B1 (en)
CN (1) CN1086290C (en)
AT (1) ATE288266T1 (en)
AU (1) AU716120B2 (en)
CA (1) CA2221370C (en)
DE (2) DE122009000072I2 (en)
ES (1) ES2232849T3 (en)
FR (1) FR12C0077I2 (en)
PT (1) PT842660E (en)
TW (1) TW371628B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
US6197808B1 (en) * 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
CN1063957C (en) 1997-09-29 2001-04-04 北京华颐中药制药厂 Method for preparing fagopyrum cymosum preparation
EP1037534A4 (en) 1997-09-29 2005-04-06 China Innovation Ct For Life S A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof
EP0938897A1 (en) * 1997-12-26 1999-09-01 Japanese Foundation For Cancer Research Telomerase inhibitor
US6030622A (en) * 1998-06-23 2000-02-29 Shehadeh; Ahmad Abdallah Herbal extract composition and method with immune-boosting capability
US6492389B1 (en) * 1998-07-21 2002-12-10 Thomas Jefferson University Small molecule inhibitors of BCL-2 proteins
KR100319973B1 (en) * 1998-12-05 2002-04-22 이인수 Cervical epithelial tumor prophylaxis or treatment composition using green tea catechin as an active ingredient
CA2440017A1 (en) 2001-05-03 2002-11-14 Cornell Research Foundation, Inc. Treatment of hpv caused diseases
DE10156794B4 (en) 2001-11-19 2006-05-18 Medigene Ag Medicines for the treatment of warts
MXPA04004532A (en) 2001-11-19 2004-08-11 Medigene Ag Medicament for the treatment of viral skin and tumour diseases.
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US20050096281A1 (en) * 2002-03-01 2005-05-05 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
AU2003228777C1 (en) * 2002-04-30 2009-08-13 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US7780992B2 (en) 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
BRPI0409179A (en) * 2003-04-04 2006-05-02 Unigen Pharmaceuticals Inc formulation of dual cyclooxygenase (cox) and lipoxygenase (lox) inhibitors for mammalian skin care
US7763588B2 (en) * 2003-06-13 2010-07-27 The Salk Institute For Biological Studies Method for increasing cognitive function and neurogenesis
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
WO2005037300A1 (en) 2003-10-09 2005-04-28 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
CN100337690C (en) * 2005-02-07 2007-09-19 上海复旦张江生物医药股份有限公司 Evaluation of efficacy of medicine for moist wart
US20070082073A1 (en) * 2005-05-18 2007-04-12 University Of South Florida Catechin Adjuvants
US8044098B2 (en) * 2005-08-02 2011-10-25 Shenghua Guangzhou Pharmaceutical Science & Technology Co., Ltd. Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
KR100801891B1 (en) 2006-11-02 2008-02-12 한상진 Natural compositions for prevention or treatment of varginal infections
EP2179722A1 (en) 2008-10-24 2010-04-28 Heinrich-Pette-Institut für experimentelle Virologie und Immunologie Topical formation for preventing sexual transmission of viral infection
ES2349966B1 (en) * 2008-10-30 2011-11-18 Ignacio Umbert Millet TOPICAL FORMULATIONS FOR THE TREATMENT OF VERRUGAS.
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
WO2012100835A1 (en) 2011-01-28 2012-08-02 Laboratorios Del Dr. Esteve, S.A. Methods and compositions for the treatment of aids
WO2014110284A1 (en) 2013-01-09 2014-07-17 Bacterin International, Inc. Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof
IL254568B2 (en) * 2015-03-19 2023-11-01 Wendy Anne Epstein Tea catechin for the treatment for female sexual disorders
MX367243B (en) * 2016-02-04 2019-08-09 Maria Del Carmen Ramirez Olvera Composition of plant extracts that increase díderlein's bacilli, used for the treatment of sexually transmitted diseases (std) and the human papillomavirus (hpv), having an aphrodisiac effect.
CN106727275A (en) * 2016-12-15 2017-05-31 珠海聚焦先导生物研究院有限公司 A kind of suppository composition for treating vaginitis
CN107349197A (en) * 2017-07-13 2017-11-17 黄冈师范学院 A kind of application of catechin on the medicine for preparing treatment cutaneous papilloma
IT202200013867A1 (en) * 2022-06-30 2023-12-30 Lo Li Pharma Srl COMPOSITION FOR THE TREATMENT OF PAPILLOMA VIRUS (HPV) INFECTION
US12111395B2 (en) * 2023-01-30 2024-10-08 Semiconductor Components Industries, Llc Acoustic sensing of proximate obstacles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2128207B1 (en) * 1971-03-11 1974-08-02 Zyma Sa
US5159069A (en) * 1988-12-20 1992-10-27 Yamanouchi Pharmaceutical Co., Ltd. Sulfated tannins and their salts
JP2727471B2 (en) * 1989-09-14 1998-03-11 三井農林株式会社 Influenza virus infection prevention agent
JPH03141220A (en) * 1989-10-26 1991-06-17 Tsumura & Co Antiretroviral agent
JP3019996B2 (en) * 1990-03-01 2000-03-15 三井農林株式会社 Ringworm treatment
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DE4211238C2 (en) * 1992-04-03 1994-10-27 Edward I Budowskij Use of 2 ', 5'-oligoadenylates for the treatment of papillomatoses
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
GB2293548A (en) * 1994-09-29 1996-04-03 Joan Louise Hibberd Treatment of herpes infections
IT1275905B1 (en) * 1995-03-14 1997-10-24 Indena Spa POLYPHENOLIC FRACTIONS OF TEA, THEIR USE AND FORMULATIONS THAT CONTAIN THEM
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
JPH1036260A (en) * 1996-07-18 1998-02-10 Mitsui Norin Kk Enhancement of effect of anticancer agent

Also Published As

Publication number Publication date
PT842660E (en) 2005-05-31
DE69732402T2 (en) 2006-01-19
DE122009000072I1 (en) 2010-03-25
ATE288266T1 (en) 2005-02-15
FR12C0077I1 (en) 2013-02-01
CA2221370A1 (en) 1998-05-18
JPH10147525A (en) 1998-06-02
DE122009000072I2 (en) 2011-07-21
DE69732402D1 (en) 2005-03-10
JP3213557B2 (en) 2001-10-02
KR100312252B1 (en) 2002-02-19
EP0842660B1 (en) 2005-02-02
ES2232849T3 (en) 2005-06-01
KR19980042555A (en) 1998-08-17
TW371628B (en) 1999-10-11
CA2221370C (en) 2004-03-02
CN1086290C (en) 2002-06-19
EP0842660A1 (en) 1998-05-20
US5795911A (en) 1998-08-18
CN1185947A (en) 1998-07-01
AU4443897A (en) 1998-06-04
AU716120B2 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
FR12C0077I2 (en) Composition for the treatment of genital warts
FR07C0046I2 (en) BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
MA25823A1 (en) COMPOSITIONS FOR THE TREATMENT OF WATER.
DE69728594D1 (en) Chromium-free composition for the treatment of metal surfaces
DE60019158D1 (en) NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF HERZARRYTHMIES
DZ3014A1 (en) Medicines for the treatment of hypertension.
DE69519577D1 (en) PREDNISOLONMETASULFOBENZOATE COMPOSITION FOR TREATING INFLAMMATORY DISEASE OF THE COLON
FR2705966B1 (en) Antifoam compositions useful in particular for the treatment of gastric disorders.
FR2786390B1 (en) CORRECTION COTYL FOR USE IN THE TREATMENT OF HIP CONDITIONS
DE69622461D1 (en) Surface treatment composition
FR2758465B1 (en) COMPOSITION FOR THE TREATMENT OF ASBESTOS
DZ2665A1 (en) Conjugates useful for the treatment of prostate cancer.
FR2746658B1 (en) IMPLANTABLE DRAINAGE VALVE FOR THE TREATMENT OF HYDROCEPHALIA
MA24569A1 (en) FARNESYL-TRANSFERASE INHIBITORS IN ASSOCIATION WITH HMG-COA-REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
MA23837A1 (en) BENZAMIDES FOR THE TREATMENT OF NEUROLOGICAL DEGENERES
MA25852A1 (en) METHOD FOR THE TREATMENT OF INFLAMMATION.
DZ3225A1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES
FR2694384B1 (en) Surface treatment of refractories.
FR2786096B1 (en) COMPOSITION FOR THE PREVENTION AND TOPICAL TREATMENT OF CELLULITE
FR2751544B1 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF VULGAR WARTS
DZ1988A1 (en) Combination therapy for the treatment of winter.
FR2721930B1 (en) OLIGONUCLEOTIDES TO INHIBIT THE ROLE OF ISOPRENYL PROTEIN TRANSFERASES
DZ3320A1 (en) Complex comprising eletriptane and sulphobutylether-cyclodextrin for the treatment of migraine
FR2751637B1 (en) ELECTROCOAGULATION CELL FOR THE TREATMENT OF EFFLUENTS